Cardiol Therapeutics Inc.

Toronto Stock Exchange:CRDL.TO

Location

Market Cap

USD 124.76 M

Share Price

USD 1.38

Avg Daily Volume

74,290

Change (1 day)

13.20%

Change (1 year)

-37.50%

Change (YTD)

7.41%

Cardiol Therapeutics Inc. Income Statement 2017 - 2024

This table shows the Income Statement for Cardiol Therapeutics Inc. going from 2017 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.

Income Statement

Annual data in millions of USD, except per share data Trend